Excerpt from Ru-486, Status Report on the U. S. Commercialization Project, Transfer of Antiprogestin Technology to the United States: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, Second Session; May 16, 1994
Chairman wyden. Welcome, Congresswoman Schroeder. We know that you have been mobilizing support for these kinds of women's health issues for many, many years and have done much to make this day possible. We, will make any prepared remarks you would like a part of the record. Please proceed as you wish.
About the Publisher
Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com
This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.
"synopsis" may belong to another edition of this title.
Shipping:
FREE
From United Kingdom to U.S.A.
Seller: Forgotten Books, London, United Kingdom
Paperback. Condition: New. Print on Demand. This book records the proceedings of a 1994 subcommittee hearing regarding the commercialization of the drug RU-486 in the United States. The book contextualizes the hearings by describing the social and political battles that had been waged in the United States over reproductive rights, including earlier attempts by the Bush administration to suppress RU-486. The book follows the testimony of Roussel-Uclaf, the maker of RU-486, and the Population Council, a non-profit foundation; both entities had been lobbying the FDA to approve the sale of RU-486 in the US. The book gives a blow-by-blow account of the hearings, delving into the scientific data regarding RU-486's safety and efficacy and laying bare the complexities of the drug's potential political uses, especially in light of the abortion debate. Ultimately, the book demonstrates the role that the pharmaceutical industry plays in shaping drug policy that has far-reaching social and political consequences, balancing scientific and medical advancements against government regulation and public opinion. This book is a reproduction of an important historical work, digitally reconstructed using state-of-the-art technology to preserve the original format. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in the book. print-on-demand item. Seller Inventory # 9781334788680_0
Quantity: Over 20 available
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # LW-9781334788680
Quantity: 15 available
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # LW-9781334788680
Quantity: 15 available